An abdominal aortic aneurysm (AAA) is a localized bulging or abnormal enlargement of the abdominal aorta (the largest artery in the human body), most often the infrarenal and aorto-iliac arteries. AAAs occur most often in Caucasian males over the age of 65 years; they are less common in women.

Endovascular aneurysm repair (EVAR) is a minimally invasive alternative to major open surgery for the repair of AAA’s that results in reduced recovery times and potentially improved survival rates. It is a type of endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA). Endovascular procedures aim to reduce the morbidity and mortality of treating arterial disease in a patient population that is increasingly older and less fit than when major open repairs were developed and popularized.

Growing numbers of geriatric population and associated expenditure for health care, steadily increasing cases of AAA screening worldwide are likely to fuel growth over the coming years. Postoperative complications like Endoleaks and migration is the biggest challenge faced by the industry. Also the growing number of regulations posed by regulatory authorities like FDA restricts the industry players. Some of the trends impacting the market include ongoing clinical studies, growing use of percutaneous EVAR, preferences for various AAA repair methods, and technological developments.

This report assesses the global EVAR market in terms of both market volume and market value on the global and regional level. The increasing competition in the EVAR industry has been analyzed on a variety of factors: revenue, surgical outcomes, postoperative procedures and complications. The top three companies having a vicious competition with each other and dominating the EVAR industry are- Medtronic, TriVascular and Lombard Medical. These players are being profiled in the report along with their key financials and strategies for growth.

Table of Contents

1. Abdominal Aortic Aneurysm (AAA)
1.1 Overview
1.1.1 Signs & Symptoms
1.1.2 Diagnosis
1.1.3 Management
1.2 Global Market Analysis
Market Penetration
Market Segmentation
1.3 Regional Market Comparison
1.3.1 On the Basis of Diagnosed Cases & Procedures Performed
United States
Europe
1.3.2 On the Basis of Prevalence by Gender
United States
Europe
1.3.3 On the Basis of Prevalence by Population
United States
Europe
1.3.4 On the Basis of Procedure Mix
United States
Europe

2. Endovascular Aneurysm Repair (EVAR)
2.1 Overview
2.1.1 Medical Applications
2.1.2 Adjunctive Procedures
2.1.3 Techniques
2.1.4 Complications
2.2 Global Market Analysis
Market Value (Actual & Forecasted)
Regional Breakdown (Actual & Forecasted)
Price Trend of Market Segments
2.3 Regional Markets
2.3.1 The US
Market Value
Procedure Share
2.3.2 Europe
Market Value
Procedure Share
2.3.3 Rest of the World
Market Value
Procedure Share

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Ageing Population
3.1.2 Increased AAA screening
3.1.3 Suitability with Age Groups
3.2.4 Rising Healthcare Expenditure
3.2 Key Trends and Developments
3.2.1 Clinical Studies & Publications
3.2.2 Growing Adoption for PEVAR
3.2.3 Procedural Characteristics
3.2.4 Technological Developments
3.3 Challenges
3.3.1 Rising Chances of Endoleaks
3.3.2 Stringent Regulations

4. Competitive Landscape
Competitive Overview
Market Share
Market Opportunity
Competitor Comparison

5. Company Profiles
5.1 Medtronic Inc. (Endurant)
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 TriVascular (Ovation Xi)
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 Lombard Medical (Aorfix)
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies

List of Tables

Prevalence of AAA 3.0 cm or larger in the age group 50-79 years
On The Basis of Patient Characteristics
On the basis of Surgical Outcomes, Postoperative Outcome & Complications
AAA Devices Market
ELGX Nellix vs. MDT’s Endurant and WL Gore’s Excluder Grafts Comparison
Factors Driving & Preventing Adoption of New EVAR Devices

List of Charts

AAA Market by Penetration (2015)
AAA Market Segmentation by Patient Anatomy (2014)
The US AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)
European AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)
The US AAA Prevalence Model by Gender (2014-2020E)
European AAA Prevalence Model by Gender (2014-2020E)
The US AAA Prevalence Model by Population (2014-2020E)
European AAA Prevalence Model by Population (2014-2020E)
The US AAA Market by Procedure Mix (2014-2020E)
European AAA Market by Procedure Mix (2014-2020E)
Global EVAR Market by Value - Actual (2010-2015E)
Global EVAR Market by Value - Forecast (2016F-2020F)
Global EVAR Market by Region - Actual (2010-2015E)
Global EVAR Market by Region - Forecast (2016F-2020F)
Regional EVAR Market Value YoY Change (2011-2020F)
Regional EVAR Market Segment by Average Selling Price (2014-2020E)
The US EVAR Market by Value (2014-2020E)
The US EVAR Market by Procedure Mix (2014-2020E)
European EVAR Market by Value (2014-2020E)
European EVAR Market by Procedure Mix (2014-2020E)
EVAR Market by Value, ROW (2014-2020E) Figure 2.12: EVAR Market by Procedure Mix, ROW (2015E)
Global Ageing Population (2009-2014)
Suitability of Endovascular Repair with Current Stent Grafts for AAA in Korean patients (2015)
Global Healthcare Expenditure (2007-2014)
EVAR Articles in the Vascular Surgery based Publications (1990-2014E)
PEVAR Market Share in the Total EVAR Procedures (2014-2016)
PEVAR Market Opportunity
On the basis of Procedural Preference
Secondary Interventions after EVAR (2014)
Prevalence of Endoleaks & Rates of Intervention
EVAR Device Mix Market Opportunity (2015-2020)
EVAR Device Market Share by Manufacturer (2015)
Competition on Basis of Minimum Post Procedural Complications
Medtronic Sales by Business Segment (FY2015)
Medtronic’s Net Sales and Net Income (2011-2015)
TriVascular Sales by Region (2014-2015)
TriVascular Sales and Net Loss (2012-2018E)
Lombard Sales by Region (2014)
Lombard Sales and Net Loss (2012-2018E)